Long-Term Safety and Efficacy of Tralokinumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 2, p. s573, 2025. DOI: 10.25251/skin.10.supp.573. Disponível em: https://skin.dermsquared.com/skin/article/view/3392. Acesso em: 8 jun. 2025.